Join Gavin Giovannoni as he discusses advancements in the treatment of patients with multiple sclerosis using immune modulation, including currently approved and future treatment options. This discussion was developed by EXCEMED, and shared with the Global Neurology Academy community.
Immune Modulation in Multiple Sclerosis
This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany.
Prof. Ralf GoldPeer